Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson’s disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson’s disease
Authors
Keywords
-
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 127, Issue 2, Pages 131-147
Publisher
Springer Science and Business Media LLC
Online
2020-01-29
DOI
10.1007/s00702-020-02150-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease
- (2019) Constant V.M. Verschuur et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity
- (2019) Stefano Thellung et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease
- (2019) R. Durcan et al. EUROPEAN JOURNAL OF NEUROLOGY
- Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson’s Disease
- (2019) Rijan Bajracharya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mitochondria in Neuroprotection by Phytochemicals: Bioactive Polyphenols Modulate Mitochondrial Apoptosis System, Function and Structure
- (2019) Makoto Naoi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Peripheral mitochondrial function correlates with clinical severity in idiopathic Parkinson's disease
- (2019) Chiara Milanese et al. MOVEMENT DISORDERS
- Serotonin regulates mitochondrial biogenesis and function in rodent cortical neurons via the 5-HT2A receptor and SIRT1–PGC-1α axis
- (2019) Sashaina E. Fanibunda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- α-Synuclein in Parkinson’s disease: causal or bystander?
- (2019) Peter Riederer et al. JOURNAL OF NEURAL TRANSMISSION
- Possible involvement of PI3K/AKT/mTOR signaling pathway in the protective effect of selegiline (deprenyl) against memory impairment following ischemia reperfusion in rat
- (2019) Hossein Amini-Khoei et al. NEUROPEPTIDES
- Mitophagy in Parkinson’s Disease: From Pathogenesis to Treatment
- (2019) Jia Liu et al. Cells
- 3,4-Dihydroxyphenylacetaldehyde is more efficient than dopamine in oligomerizing and quinonizing alpha-synuclein
- (2019) Yunden Jinsmaa et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Nigral overexpression of α‐synuclein in a rat Parkinson’s disease model indicates alterations in the enteric nervous system and the gut microbiome
- (2019) Sarah M. O’Donovan et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Nutritional Risk Factors, Microbiota and Parkinson’s Disease: What Is the Current Evidence?
- (2019) Christa Boulos et al. Nutrients
- The catecholaldehyde hypothesis: where MAO fits in
- (2019) David S. Goldstein JOURNAL OF NEURAL TRANSMISSION
- A neuroscience perspective of the gut theory of Parkinson's disease
- (2018) Lisa M. Smith et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson’s disease
- (2018) Éva Szökő et al. JOURNAL OF NEURAL TRANSMISSION
- Monoamine oxidase-B inhibitors in the treatment of Parkinson’s disease: clinical–pharmacological aspects
- (2018) Peter Riederer et al. JOURNAL OF NEURAL TRANSMISSION
- Disease Modification for Parkinson's Disease: Axonal Regeneration and Trophic Factors
- (2018) Jeffrey H. Kordower et al. MOVEMENT DISORDERS
- Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study
- (2018) Philipp Mahlknecht et al. MOVEMENT DISORDERS
- Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations
- (2018) Anthony E. Lang et al. MOVEMENT DISORDERS
- Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson’s disease
- (2018) Diego Grassi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease
- (2018) Marthe H. R. Ludtmann et al. Nature Communications
- Exploring the Structural Diversity in Inhibitors of α-Synuclein Amyloidogenic Folding, Aggregation, and Neurotoxicity
- (2018) Sukanya Das et al. Frontiers in Chemistry
- Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons
- (2018) Jordi Pujols et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New insights into the complex role of mitochondria in Parkinson’s disease
- (2018) Anne Grünewald et al. PROGRESS IN NEUROBIOLOGY
- miR-34a/BCL-2 signaling axis contributes to apoptosis in MPP+ -induced SH-SY5Y cells
- (2018) Zahra Shanesazzade et al. Molecular Genetics & Genomic Medicine
- Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration
- (2018) Shun Zhang et al. ACS Chemical Neuroscience
- The prodromes of Parkinson's disease
- (2018) Richard Nathaniel Rees et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Aldehyde adducts inhibit 3,4-dihydroxyphenylacetaldehyde-induced α-synuclein aggregation and toxicity: implication for Parkinson neuroprotective therapy
- (2018) Vijaya B. Kumar et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Actions of Brain-Derived Neurotrophin Factor in the Neurogenesis and Neuronal Function, and Its Involvement in the Pathophysiology of Brain Diseases
- (2018) Tadahiro Numakawa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases
- (2018) Moussa B. H. Youdim JOURNAL OF NEURAL TRANSMISSION
- Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis
- (2018) Michaela E. Johnson et al. TRENDS IN NEUROSCIENCES
- Clinical approaches to the development of a neuroprotective therapy for PD
- (2017) C.W. Olanow et al. EXPERIMENTAL NEUROLOGY
- Therapeutic approaches to target alpha-synuclein pathology
- (2017) Patrik Brundin et al. EXPERIMENTAL NEUROLOGY
- Reactive oxygen species trigger Parkin/PINK1 pathway–dependent mitophagy by inducing mitochondrial recruitment of Parkin
- (2017) Bin Xiao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons
- (2017) Makoto Naoi et al. JOURNAL OF NEURAL TRANSMISSION
- Neurotrophic function of phytochemicals for neuroprotection in aging and neurodegenerative disorders: modulation of intracellular signaling and gene expression
- (2017) Makoto Naoi et al. JOURNAL OF NEURAL TRANSMISSION
- Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline
- (2017) Keiko Inaba-Hasegawa et al. JOURNAL OF NEURAL TRANSMISSION
- Mitochondrial biogenesis in neurodegeneration
- (2017) P. Andy Li et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Dietary antioxidants and risk of Parkinson's disease in two population-based cohorts
- (2017) Fei Yang et al. MOVEMENT DISORDERS
- Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease
- (2017) Zhentao Zhang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein
- (2017) Franziska Richter et al. Neurotherapeutics
- Role of Diet and Nutritional Supplements in Parkinson’s Disease Progression
- (2017) Laurie K. Mischley et al. Oxidative Medicine and Cellular Longevity
- TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson’s disease
- (2017) Seong Su Kang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
- (2017) Fabio A. Zucca et al. PROGRESS IN NEUROBIOLOGY
- Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease
- (2017) Zhentao Zhang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
- (2016) Timothy R. Sampson et al. CELL
- PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
- (2016) Juan Carlos Corona et al. FREE RADICAL BIOLOGY AND MEDICINE
- Rasagiline prevents cyclosporine A-sensitive superoxide flashes induced by PK11195, the initial signal of mitochondrial membrane permeabilization and apoptosis
- (2016) Yuqiu Wu et al. JOURNAL OF NEURAL TRANSMISSION
- Phytochemicals prevent mitochondrial membrane permeabilization and protect SH-SY5Y cells against apoptosis induced by PK11195, a ligand for outer membrane translocator protein
- (2016) Yuqiu Wu et al. JOURNAL OF NEURAL TRANSMISSION
- Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase
- (2016) M. H. R. Ludtmann et al. JOURNAL OF NEUROSCIENCE
- The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain
- (2016) Silvia Fossati et al. NEUROBIOLOGY OF DISEASE
- Structural Imaging and Parkinson’s Disease: Moving Toward Quantitative Markers of Disease Progression
- (2016) N.W. Sterling et al. Journal of Parkinsons Disease
- Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
- (2016) John P. M. Finberg et al. Frontiers in Pharmacology
- Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel in vitro assay and an in vivo Drosophila synucleinopathy model
- (2016) Deepthi Yedlapudi et al. Scientific Reports
- A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients
- (2015) P. Barone et al. EUROPEAN JOURNAL OF NEUROLOGY
- α-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease
- (2015) Tatiana K. Rostovtseva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets
- (2015) Orit Bar-Am et al. JOURNAL OF NEURAL TRANSMISSION
- Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection
- (2015) Yuqiu Wu et al. JOURNAL OF NEURAL TRANSMISSION
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein
- (2015) Yunden Jinsmaa et al. NEUROSCIENCE LETTERS
- Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis
- (2015) Sagit Golko-Perez et al. NEUROTOXICITY RESEARCH
- Aggregated α-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons
- (2015) A K Reeve et al. Cell Death & Disease
- PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein
- (2015) Carine Ciron et al. Acta Neuropathologica Communications
- Rasagiline, a Suicide Inhibitor of Monoamine Oxidases, Binds Reversibly to α-Synuclein
- (2014) Joe Kakish et al. ACS Chemical Neuroscience
- Multifunctional D2/D3 Agonist D-520 with High in Vivo Efficacy: Modulator of Toxicity of Alpha-Synuclein Aggregates
- (2014) Gyan Modi et al. ACS Chemical Neuroscience
- Effect of resveratrol on mitochondrial function: Implications in parkin-associated familiar Parkinson's disease
- (2014) Anna Ferretta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- α-Synuclein amino terminus regulates mitochondrial membrane permeability
- (2014) Jiamei Shen et al. BRAIN RESEARCH
- Cu(II) and dopamine bind to α-synuclein and cause large conformational changes
- (2014) Omid Tavassoly et al. FEBS Journal
- Bcl-2 Family Proteins Participate in Mitochondrial Quality Control by Regulating Parkin/PINK1-Dependent Mitophagy
- (2014) Emilie Hollville et al. MOLECULAR CELL
- Gut microbiota are related to Parkinson's disease and clinical phenotype
- (2014) Filip Scheperjans et al. MOVEMENT DISORDERS
- The ongoing pursuit of neuroprotective therapies in Parkinson disease
- (2014) Dilan Athauda et al. Nature Reviews Neurology
- An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore
- (2014) K. N. Alavian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
- (2013) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- HMGB1 is involved in autophagy inhibition caused by SNCA/α-synuclein overexpression
- (2013) Ju-Xian Song et al. Autophagy
- Mitochondria-targeted antioxidants for treatment of Parkinson's disease: Preclinical and clinical outcomes
- (2013) Huajun Jin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms
- (2013) Makoto Naoi et al. Expert Review of Neurotherapeutics
- Parkinson disease: from pathology to molecular disease mechanisms
- (2013) David T. Dexter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily
- (2013) Klodjan Stafa et al. HUMAN MOLECULAR GENETICS
- Rasagiline prevents apoptosis induced by PK11195, a ligand of the outer membrane translocator protein (18 kDa), in SH-SY5Y cells through suppression of cytochrome c release from mitochondria
- (2013) Makoto Naoi et al. JOURNAL OF NEURAL TRANSMISSION
- Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro
- (2013) Kenjiro Ono et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial
- (2013) Anthony HV Schapira et al. LANCET NEUROLOGY
- TOM40 Mediates Mitochondrial Dysfunction Induced by α-Synuclein Accumulation in Parkinson’s Disease
- (2013) Andreas Bender et al. PLoS One
- Promise of Neurorestoration and Mitochondrial Biogenesis in Parkinson's Disease with Multi Target Drugs: An Alternative to Stem Cell Therapy
- (2013) Moussa BH Youdim et al. Experimental Neurobiology
- Physiological Roles of the Permeability Transition Pore
- (2012) Catherine Brenner et al. CIRCULATION RESEARCH
- Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders
- (2012) Makoto Naoi et al. CURRENT PHARMACEUTICAL DESIGN
- Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: Implications for Parkinson’s disease
- (2012) Almas Siddiqui et al. FREE RADICAL BIOLOGY AND MEDICINE
- Switch from selegiline to rasagiline is beneficial in patients with Parkinson’s disease
- (2012) Thomas Müller et al. JOURNAL OF NEURAL TRANSMISSION
- ‘‘70th Birthday Professor Riederer’’ Induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (−)deprenyl: a way to a disease-modifying therapy?
- (2012) Wakako Maruyama et al. JOURNAL OF NEURAL TRANSMISSION
- Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells
- (2012) Keiko Inaba-Hasegawa et al. JOURNAL OF NEURAL TRANSMISSION
- Acid β-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α-synuclein processing
- (2011) Valerie Cullen et al. ANNALS OF NEUROLOGY
- Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease
- (2011) Consiglia Pacelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Association of PGC-1alphapolymorphisms with age of onset and risk of Parkinson's disease
- (2011) Joanne Clark et al. BMC Medical Genetics
- Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
- (2011) Mario Caruana et al. FEBS LETTERS
- Increase expression of α-synuclein in aged human brain associated with neuromelanin accumulation
- (2011) Qi Xuan et al. JOURNAL OF NEURAL TRANSMISSION
- Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase
- (2011) Keiko Inaba-Hasegawa et al. JOURNAL OF NEURAL TRANSMISSION
- Neurotoxin-based models of Parkinson's disease
- (2011) J. Bové et al. NEUROSCIENCE
- Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions
- (2011) Matthias Elstner et al. Molecular Brain
- Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro
- (2011) W Dimpfel et al. BMC Pharmacology & Toxicology
- Age-related protective effect of deprenyl on changes in the levels of diagnostic marker enzymes and antioxidant defense enzymes activities in cerebellar tissue in Wistar rats
- (2010) Manju V. Subramanian et al. CELL STRESS & CHAPERONES
- DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy
- (2010) Kelly Jean Thomas et al. HUMAN MOLECULAR GENETICS
- The Anti-Parkinsonian Drug Selegiline Delays the Nucleation Phase of α-Synuclein Aggregation Leading to the Formation of Nontoxic Species
- (2010) Carolina A. Braga et al. JOURNAL OF MOLECULAR BIOLOGY
- R-Deprenyl: Pharmacological Spectrum of its Activity
- (2010) K. Magyar et al. NEUROCHEMICAL RESEARCH
- Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells
- (2010) K.Y. Chau et al. NEUROCHEMISTRY INTERNATIONAL
- Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo
- (2010) Shankar J. Chinta et al. NEUROSCIENCE LETTERS
- Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy
- (2010) Leslie Crews et al. PLoS One
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases
- (2009) Latha Devi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects inCol6a1−/−myopathic mice
- (2009) T Tiepolo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nix is a selective autophagy receptor for mitochondrial clearance
- (2009) Ivana Novak et al. EMBO REPORTS
- Evaluation of putative inhibitors of mitochondrial permeability transition for brain disorders — Specificity vs. toxicity
- (2009) Saori Morota et al. EXPERIMENTAL NEUROLOGY
- Mitochondrial dynamics in Parkinson's disease
- (2009) Victor S. Van Laar et al. EXPERIMENTAL NEUROLOGY
- Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease
- (2009) Hansruedi Büeler EXPERIMENTAL NEUROLOGY
- Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival
- (2009) Makoto Naoi et al. JOURNAL OF NEURAL TRANSMISSION
- PINK1 Defect Causes Mitochondrial Dysfunction, Proteasomal Deficit and α-Synuclein Aggregation in Cell Culture Models of Parkinson's Disease
- (2009) Wencheng Liu et al. PLoS One
- Methazolamide and Melatonin Inhibit Mitochondrial Cytochrome C Release and Are Neuroprotective in Experimental Models of Ischemic Injury
- (2009) Xin Wang et al. STROKE
- A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders
- (2008) Kurt A. Jellinger BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Quality control of mitochondria: protection against neurodegeneration and ageing
- (2008) Takashi Tatsuta et al. EMBO JOURNAL
- α-Synuclein Protofibrils Inhibit 26 S Proteasome-mediated Protein Degradation
- (2008) Nan-Yan Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells
- (2008) Tereza Vogiatzi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuromelanin selectively induces apoptosis in dopaminergic SH-SY5Y cells by deglutathionylation in mitochondria: involvement of the protein and melanin component
- (2008) Makoto Naoi et al. JOURNAL OF NEUROCHEMISTRY
- A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics
- (2008) C. Warren Olanow et al. MOVEMENT DISORDERS
- Elevated α-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease
- (2008) Jan Gründemann et al. NUCLEIC ACIDS RESEARCH
- Nortriptyline Protects Mitochondria and Reduces Cerebral Ischemia/Hypoxia Injury
- (2008) Wen-hua Zhang et al. STROKE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search